# Puma Biotechnology (PBYI) — News

PBYI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pbyi/news

## Recent headlines

- [JSE: BYI - Results for the six months ended 31 August 2026 and declaration of cash dividend](https://www.ainvest.com/news/jse-byi-results-months-ended-31-august-2026-declaration-cash-dividend-2610) — AInvest Wire, Oct 13, 2026
- [Anta Sports completes acquisition of 29.06% stake in Puma, becomes largest shareholder](https://www.ainvest.com/news/anta-sports-completes-acquisition-29-06-stake-puma-largest-shareholder-2610) — AInvest Wire, Oct 7, 2026
  In a significant development for the global sportswear industry, Anta Sports has completed its acquisition of a 29.06% stake in PUMA Group SE for €1.51 billion ($1.79 billion), making it the German brand’s largest shareholder . The transaction involved the purchase of 43 million shares at €35 each,…
- [Anta Sports Products - Completes acquisition of 29.06% equity interest in Puma SE](https://www.ainvest.com/news/anta-sports-products-completes-acquisition-29-06-equity-interest-puma-se-2610) — AInvest Wire, Oct 7, 2026
  Anta Sports Products Limited has completed the acquisition of a 29.06% equity interest in Puma SE, a German-based global sportswear brand, for €1.5 billion in cash. The transaction involves the purchase of 43.01 million shares at €35 per share, making Anta the largest shareholder in Puma despite…
- [Puma SE: Jefferies cuts target price to EUR 23.5 from EUR 27.5](https://www.ainvest.com/news/puma-se-jefferies-cuts-target-price-eur-23-5-eur-27-5-2610) — AInvest Wire, Oct 6, 2026
  Jefferies has revised its target price for Puma SE (0NQE.IL) from EUR 23.5 to EUR 27.5, reflecting updated expectations for the company's performance amid ongoing challenges. The adjustment follows Puma's Q2 2025 earnings report, which revealed a 2% decline in sales to €1.94 billion in constant…
- [Puma Biotechnology reports inducement award under Nasdaq listing rule 5635(C)(4)](https://www.ainvest.com/news/puma-biotechnology-reports-inducement-award-nasdaq-listing-rule-5635-4-2610) — AInvest Wire, Oct 5, 2026

## Similar Stocks

- [ADMA](https://www.lighthorse.io/tickers/adma) — ADMA Biologics Inc - Common Stock
- [CTMX](https://www.lighthorse.io/tickers/ctmx) — CytomX Therapeutics, Inc. - Common Stock
- [TRDA](https://www.lighthorse.io/tickers/trda) — Entrada Therapeutics, Inc. - Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).